G. Magliocco

Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity

Y. Daali, L. Marcourt, J. Desmeules, 2021, British journal of pharmacology.

METABOLOMICS REVEALS FIVE ENDOGENOUS BIOMARKERS IN HUMAN URINE AND PLASMA TO PREDICT CYP2D6 ACTIVITY

Y. Daali, J. Desmeules, Aurélien Thomas, 2021 .

Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6‐hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots

Y. Daali, J. Desmeules, Aurélien Thomas, 2022, Clinical and translational science.

Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MS.

Y. Daali, J. Desmeules, A. Thomas, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker?

Y. Daali, J. Desmeules, Aurélien Thomas, 2021, Journal of personalized medicine.

Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling

Y. Daali, J. Desmeules, F. Rodieux, 2019, Pediatric Research.

The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitro

Y. Daali, V. Cagno, C. Tapparel, 2020, Basic & clinical pharmacology & toxicology.

Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches

Y. Daali, J. Desmeules, Aurélien Thomas, 2019, Clinical Pharmacokinetics.

Modern approaches for the phenotyping of cytochrome P450 enzymes in children

Y. Daali, G. Magliocco, 2020, Expert review of clinical pharmacology.

Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail

Y. Daali, J. Desmeules, C. Samer, 2019, Journal of personalized medicine.